Not all fat is equal: Differential gene expression and potential therapeutic targets in subcutaneous adipose, visceral adipose, and endometrium of obese women with and without endometrial cancer

International Journal of Gynecological Cancer

Volumn 22, Issue 5, 2012, Pages 732-741

  Modesitt, Susan C ^a   Hsu, Jennifer Y ^b   Chowbina, Sudhir R ^c   Lawrence, Robert T ^a   Hoehn, Kyle L ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c SAIC FREDERICK INC   (United States)

Author keywords

De novo lipogenesis; Endometrial cancer; Obesity

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADENOSINE PHOSPHATE; LIPID; LIVER ENZYME; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

ADULT; ARTICLE; BODY MASS; CANCER RISK; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; ENDOMETRIUM; ENDOMETRIUM CANCER; ENRICHMENT CULTURE; ENZYME ACTIVITY; ESCHERICHIA COLI INFECTION; FEMALE; GENE EXPRESSION REGULATION; GLUCONEOGENESIS; GLYCOLYSIS; HORMONE DETERMINATION; HUMAN; HUMAN TISSUE; HYSTERECTOMY; INTRAABDOMINAL FAT; LIPOGENESIS; MICROARRAY ANALYSIS; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RIBOSOME; SERUM; SIGNAL TRANSDUCTION; SUBCUTANEOUS FAT; TUMOR GENE; UPREGULATION;

ADIPOSITY; ADULT; BLOTTING, WESTERN; BODY MASS INDEX; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INTRA-ABDOMINAL FAT; MIDDLE AGED; OBESITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; SUBCUTANEOUS FAT; TUMOR MARKERS, BIOLOGICAL;

EID: 84863688356     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e3182510496     Document Type: Article

References (29)

1. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277-300.
2. Modesitt SC, van Nagell JR Jr. The impact of obesity on the incidence and treatment of gynecologic cancers: a review. Obstet Gynecol Surv. 2005;60:683-692. (Pubitemid 41368535)
3. Akhmedkhanov A, Zeleniuch-Jacquotte A, Toniolo P. Role of exogenous and endogenous hormones in endometrial cancer: review of the evidence and research perspectives. Ann N Y Acad Sci. 2001;943:296-315. (Pubitemid 32928322)
4. Gangemi M, Meneghetti G, Predebon O, et al. Obesity as a risk factor for endometrial cancer. Clin Exp Obstet Gynecol. 1987;14:119-122.
5. You T, Yang R, Lyles MF, et al. Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors. Am J Physiol Endocrinol Metab. 2005;288:E741-E747. (Pubitemid 40397209)
6. Nieman KM, Kenny HA, Penicka CV, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med. [10.1038/nm.2492]. 2011;17:1498-1503.
7. Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer. 2007;7:763-777. (Pubitemid 47469806)
8. Pizer ES, Kurman RJ, Pasternack GR, et al. Expression of fatty acid synthase is closely linked to proliferation and stromal decidualization in cycling endometrium. Int J Gynecol Pathol. 1997;16:45-51. (Pubitemid 27199585)
9. Modesitt SC, Geffel DL, Via J, et al. Morbidly obese women with and without endometrial cancer: are there differences in measured physical fitness, body composition, or hormones? Gynecol Oncol. 2012;124:431-436.
10. Reich M, Liefeld T, Gould J, et al. GenePattern 2.0. Nat Genet. 2006;38:500-501.
11. Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27-30. (Pubitemid 30047706)
12. Lu KH, Wu W, Dave B, et al. Loss of tuberous sclerosis complex-2 function and activation of mammalian target of rapamycin signaling in endometrial carcinoma. Clin Cancer Res. 2008;14:2543-2550.
13. Laughlin GA, Barrett-Connor E, May S. Sex-specific determinants of serum adiponectin in older adults: the role of endogenous sex hormones. Int J Obes (Lond). 2007;31:457-465.
14. Kusakabe T, Maeda M, Hoshi N, et al. Fatty acid synthase is expressed mainly in adult hormone-sensitive cells or cells with high lipid metabolism and in proliferating fetal cells. J Histochem Cytochem. 2000;48:613-622. (Pubitemid 30233185)
15. Lupu R, Menendez JA. Targeting fatty acid synthase in breast and endometrial cancer: an alternative to selective estrogen receptor modulators? Endocrinology. 2006;147:4056-4066. (Pubitemid 44274975)
16. Abramson HN. The lipogenesis pathway as a cancer target. J Med Chem. 2011;54:5615-5638.
17. Sanchez-Cespedes M, Parrella P, Esteller M, et al. Inactivation of LKB1/STK11 Is a common event in adenocarcinomas of the lung. Cancer Res. 2002;62: 3659-3662. (Pubitemid 34728843)
18. Awazawa M, Ueki K, Inabe K, et al. Adiponectin suppresses hepatic SREBP1c expression in an AdipoR1/LKB1/AMPK dependent pathway. Biochem Biophys Res Commun. 2009;382:51-56.
19. Holland WL, Miller RA, Wang ZV, et al. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med. 2011;17:55-63.
20. Ogretmen B, Hannun YA. Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer. 2004;4:604-616. (Pubitemid 39025055)
21. Takai N, Ueda T, Kawano Y, et al. C2-ceramide exhibits antiproliferative activity and potently induces apoptosis in endometrial carcinoma. Oncol Rep. 2005;14: 1287-1291.
22. Knapp P, Baranowski M, Knapp M, et al. Altered sphingolipid metabolism in human endometrial cancer. Prostaglandins Other Lipid Mediat. 2010;92:62-66.
23. Swinnen JV, Brusselmans K, Verhoeven G. Increased lipogenesis in cancer cells: new players, novel targets. Curr Opin Clin Nutr Metab Care. 2006;9:358-365. (Pubitemid 44101970)
24. Rzepka-Gorska I, Bedner R, Cymbaluk-Ploska A, et al. Serum adiponectin in relation to endometrial cancer and endometrial hyperplasia with atypia in obese women. Eur J Gynaecol Oncol. 2008;29:594-597.
25. Soliman PT, Wu D, Tortolero-Luna G, et al. Association between adiponectin, insulin resistance, and endometrial cancer. Cancer. 2006;106:2376-2381. (Pubitemid 43787661)
26. Yamauchi T, Kadowaki T. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases. Int J Obes (Lond). 2008;32(suppl 7):S13-S18.
27. Holland CM, Saidi SA, Evans AL, et al. Transcriptome analysis of endometrial cancer identifies peroxisome proliferator-activated receptors as potential therapeutic targets. Mol Cancer Ther. 2004;3:993-1001. (Pubitemid 39199594)
28. Ashizawa N, Yahata T, Quan J, et al. Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects. Gynecol Oncol. 2010;119:65-69.
29. Dewdney SB, Rimel B, Thaker PH, et al. Aberrant methylation of the X-linked ribosomal S6 kinase RPS6KA6 (RSK4) in endometrial cancers. Clin Cancer Res. 2011;17:2120-2129.